Full Text
PRO79 EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Abstract

Authors

F.J. Badia J.L. Poveda M. Tort V. Tania J. Shepherd

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×